ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[이데일리] 단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’
2020/10/13
단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’ (edaily.co.kr)
이데일리 류성 기자
Prev
[서울경제] [주목!바이오벤처-큐로셀] “고형암도 치료 가능한 CAR-T…연내 임상 시작”
Next
[한경 BIO Insight] [Cover Story – part.5] 큐로셀, CAR-T 뛰어넘는 CAR-T 개발
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.